Weight Management

Policy

Medicare GLP-1 Bridge: Why Lower Prices Still Fall Short

Jun 28, 2026

•

6 min read

Medicare GLP-1 Bridge: Why Lower Prices Still Fall Short

Jared Dashevsky, MD

Huddle Trends

GLP-1 Drugs, Digital Health & Obesity Trends in 2026

Mar 8, 2026

•

1 min read

GLP-1 Drugs, Digital Health & Obesity Trends in 2026

Huddle #Trends

Jared Dashevsky, MD

Weight Management

Feb 15, 2026

•

2 min read

The GLP-1 Compounding Crackdown

Jared Dashevsky, MD

Weight Management

GLP-1 Discontinuation: What It Means for Weight Loss Brands

Feb 16, 2025

•

10 min read

GLP-1 Discontinuation: What It Means for Weight Loss Brands

Jared Dashevsky, MD

Weight Management

Dec 15, 2024

•

9 min read

How Niches Will Shape the Crowded Weight Management Market

Jared Dashevsky, MD

Huddle Trends

The Future of Obesity Care: GLP-1s, Compounding & Surgery Trends

Nov 3, 2024

•

4 min read

The Future of Obesity Care: GLP-1s, Compounding & Surgery Trends

Huddle #Trends

Jared Dashevsky, MD

Weight Management

Are Continuous Glucose Monitors Worth It for Those Without Diabetes?

Oct 13, 2024

•

9 min read

Are Continuous Glucose Monitors Worth It for Those Without Diabetes?

Jared Dashevsky, MD

Weight Management

23andMe’s New GLP-1 Service: Exploring Compounded Medications

Aug 25, 2024

•

9 min read

23andMe’s New GLP-1 Service: Exploring Compounded Medications

Jared Dashevsky, MD

Weight Management

Dexcom and Abbott’s FDA-Cleared CGMs: A Consumer Market Revolution

Jun 9, 2024

•

12 min read

Dexcom and Abbott’s FDA-Cleared CGMs: A Consumer Market Revolution

Jared Dashevsky, MD

Huddle Trends

Navigating Obesity Care in the Digital Age

Mar 3, 2024

•

4 min read

Navigating Obesity Care in the Digital Age

Huddle+ | Huddle #Trends

Jared Dashevsky, MD

Drug Supply Chain

Jan 7, 2024

•

5 min read

Compounding Pharmacy

Healthcare Concepts

Jared Dashevsky, MD

Medicine

Semaglutide: A Medical Marvel or an Economic Enigma?

Sep 23, 2023

•

8 min read

Semaglutide: A Medical Marvel or an Economic Enigma?

Jared Dashevsky, MD

Medicine

I Was Right (and Wrong) About the Weight Management Space

Jun 10, 2023

•

8 min read

I Was Right (and Wrong) About the Weight Management Space

Jared Dashevsky, MD

Weight Management

Feb 18, 2023

•

9 min read

Do Weight-management Startups Have a Future?

Jared Dashevsky, MD

Medicine

Dec 17, 2022

•

11 min read

The Future of Obesity Care

Jared Dashevsky, MD

Medicine

Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation

Oct 8, 2022

•

5 min read

Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation

Jared Dashevsky, MD

Medicine

May 1, 2022

•

4 min read

The Next Frontier of Weight Loss

Jared Dashevsky, MD

Weight Management

Medicare GLP-1 Bridge: Why Lower Prices Still Fall Short

GLP-1 Drugs, Digital Health & Obesity Trends in 2026

The GLP-1 Compounding Crackdown

GLP-1 Discontinuation: What It Means for Weight Loss Brands

How Niches Will Shape the Crowded Weight Management Market

The Future of Obesity Care: GLP-1s, Compounding & Surgery Trends

Are Continuous Glucose Monitors Worth It for Those Without Diabetes?

23andMe’s New GLP-1 Service: Exploring Compounded Medications

Dexcom and Abbott’s FDA-Cleared CGMs: A Consumer Market Revolution

Navigating Obesity Care in the Digital Age

Compounding Pharmacy

Semaglutide: A Medical Marvel or an Economic Enigma?

I Was Right (and Wrong) About the Weight Management Space

Do Weight-management Startups Have a Future?

The Future of Obesity Care

Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation

The Next Frontier of Weight Loss

Healthcare Huddle